198 related articles for article (PubMed ID: 29158292)
1. Sphingomyelin Metabolism Is a Regulator of K-Ras Function.
van der Hoeven D; Cho KJ; Zhou Y; Ma X; Chen W; Naji A; Montufar-Solis D; Zuo Y; Kovar SE; Levental KR; Frost JA; van der Hoeven R; Hancock JF
Mol Cell Biol; 2018 Feb; 38(3):. PubMed ID: 29158292
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Acid Sphingomyelinase Depletes Cellular Phosphatidylserine and Mislocalizes K-Ras from the Plasma Membrane.
Cho KJ; van der Hoeven D; Zhou Y; Maekawa M; Ma X; Chen W; Fairn GD; Hancock JF
Mol Cell Biol; 2016 Jan; 36(2):363-74. PubMed ID: 26572827
[TBL] [Abstract][Full Text] [Related]
3. Avicin G is a potent sphingomyelinase inhibitor and blocks oncogenic K- and H-Ras signaling.
Garrido CM; Henkels KM; Rehl KM; Liang H; Zhou Y; Gutterman JU; Cho KJ
Sci Rep; 2020 Jun; 10(1):9120. PubMed ID: 32499517
[TBL] [Abstract][Full Text] [Related]
4. An oxanthroquinone derivative that disrupts RAS plasma membrane localization inhibits cancer cell growth.
Tan L; Cho KJ; Neupane P; Capon RJ; Hancock JF
J Biol Chem; 2018 Aug; 293(35):13696-13706. PubMed ID: 29970615
[TBL] [Abstract][Full Text] [Related]
5. Sphingomyelin metabolism at the plasma membrane: implications for bioactive sphingolipids.
Milhas D; Clarke CJ; Hannun YA
FEBS Lett; 2010 May; 584(9):1887-94. PubMed ID: 19857494
[TBL] [Abstract][Full Text] [Related]
6. Sphingomyelin metabolism underlies Ras excitability for efficient cell migration and chemotaxis.
Shin DY; Takagi H; Hiroshima M; Matsuoka S; Ueda M
Cell Struct Funct; 2023 Aug; 48(2):145-160. PubMed ID: 37438131
[TBL] [Abstract][Full Text] [Related]
7. Features of Ras activation by a mislocalized oncogenic tyrosine kinase: FLT3 ITD signals through K-Ras at the plasma membrane of acute myeloid leukemia cells.
Köthe S; Müller JP; Böhmer SA; Tschongov T; Fricke M; Koch S; Thiede C; Requardt RP; Rubio I; Böhmer FD
J Cell Sci; 2013 Oct; 126(Pt 20):4746-55. PubMed ID: 23943874
[TBL] [Abstract][Full Text] [Related]
8. Ras farnesyltransferase inhibitors suppress the phenotype resulting from an activated ras mutation in Caenorhabditis elegans.
Hara M; Han M
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3333-7. PubMed ID: 7536929
[TBL] [Abstract][Full Text] [Related]
9. Fendiline inhibits K-Ras plasma membrane localization and blocks K-Ras signal transmission.
van der Hoeven D; Cho KJ; Ma X; Chigurupati S; Parton RG; Hancock JF
Mol Cell Biol; 2013 Jan; 33(2):237-51. PubMed ID: 23129805
[TBL] [Abstract][Full Text] [Related]
10. Rapid replenishment of sphingomyelin in the plasma membrane upon degradation by sphingomyelinase in NIH3T3 cells overexpressing the phosphatidylinositol transfer protein beta.
Van Tiel CM; Luberto C; Snoek GT; Hannun YA; Wirtz KW
Biochem J; 2000 Mar; 346 Pt 2(Pt 2):537-43. PubMed ID: 10677376
[TBL] [Abstract][Full Text] [Related]
11. Inhibitors of K-Ras plasma membrane localization.
Cho KJ; van der Hoeven D; Hancock JF
Enzymes; 2013; 33 Pt A():249-65. PubMed ID: 25033808
[TBL] [Abstract][Full Text] [Related]
12. MEK-2, a Caenorhabditis elegans MAP kinase kinase, functions in Ras-mediated vulval induction and other developmental events.
Wu Y; Han M; Guan KL
Genes Dev; 1995 Mar; 9(6):742-55. PubMed ID: 7729690
[TBL] [Abstract][Full Text] [Related]
13. Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans.
van der Hoeven D; Truong TNL; Naji A; Thapa S; Hancock JF; van der Hoeven R
J Vis Exp; 2020 Oct; (164):. PubMed ID: 33074252
[TBL] [Abstract][Full Text] [Related]
14. AMPK and Endothelial Nitric Oxide Synthase Signaling Regulates K-Ras Plasma Membrane Interactions via Cyclic GMP-Dependent Protein Kinase 2.
Cho KJ; Casteel DE; Prakash P; Tan L; van der Hoeven D; Salim AA; Kim C; Capon RJ; Lacey E; Cunha SR; Gorfe AA; Hancock JF
Mol Cell Biol; 2016 Dec; 36(24):3086-3099. PubMed ID: 27697864
[TBL] [Abstract][Full Text] [Related]
15. Acid sphingomyelinase is required for cell surface presentation of Met receptor tyrosine kinase in cancer cells.
Zhu L; Xiong X; Kim Y; Okada N; Lu F; Zhang H; Sun H
J Cell Sci; 2016 Nov; 129(22):4238-4251. PubMed ID: 27802163
[TBL] [Abstract][Full Text] [Related]
16. The role of acid sphingomyelinase and modulation of sphingolipid metabolism in bacterial infection.
Simonis A; Schubert-Unkmeir A
Biol Chem; 2018 Sep; 399(10):1135-1146. PubMed ID: 29924727
[TBL] [Abstract][Full Text] [Related]
17. Impact of Nrf2 on tumour growth and drug sensitivity in oncogenic K-ras-transformed cells in vitro and in vivo.
Shao J; Glorieux C; Liao J; Chen P; Lu W; Liang Z; Wen S; Hu Y; Huang P
Free Radic Res; 2018 Jun; 52(6):661-671. PubMed ID: 29621903
[TBL] [Abstract][Full Text] [Related]
18. Blocking K-Ras Interaction With the Plasma Membrane Is a Tractable Therapeutic Approach to Inhibit Oncogenic K-Ras Activity.
Henkels KM; Rehl KM; Cho KJ
Front Mol Biosci; 2021; 8():673096. PubMed ID: 34222333
[TBL] [Abstract][Full Text] [Related]
19. Molecular species of sphingomyelin in sphingomyelinase-sensitive and sphingomyelinase-resistant pools of HL-60 cells.
Fitzgerald V; Blank ML; Snyder F
Lipids; 1995 Sep; 30(9):805-9. PubMed ID: 8577223
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel Ras-regulated proapoptotic pathway.
Khokhlatchev A; Rabizadeh S; Xavier R; Nedwidek M; Chen T; Zhang XF; Seed B; Avruch J
Curr Biol; 2002 Feb; 12(4):253-65. PubMed ID: 11864565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
